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ABSTRACT
Objectives: The aim of this study was to evaluate the relationship between in vitro fertilization (IVF) cycle outcomes, serum 
and follicular fluid (FF) levels of leptin and ghrelin. 
Material and methods: Forty-four women who underwent intracytoplasmic sperm injection cycles (ICSI) were enrolled 
in the study. On the third day (D3) of the menstrual cycle, venous blood samples were drawn for serum measurements 
of leptin and ghrelin. The follicular fluid (FF) and the corresponding oocyte were obtained from a single dominant preo-
vulatory follicle at the time of oocyte pick-up. The FF and D3 serum leptin and ghrelin concentrations were measured by 
enzyme-linked immunosorbent assay. The relationship between pregnancy rate and serum, follicular fluid levels of leptin 
and ghrelin were analyzed. 
Results: Of the 44 cases included, nineteen achieved clinical pregnancy (43.18%). Follicular fluid ghrelin levels were signifi-
cantly lower in the pregnant group than non-pregnant group (p < 0.05) With respect to FF leptin, there was no statistically 
significant differences between the pregnant and non-pregnant women (p > 0.05). There was no statistically significant 
difference in D3 serum ghrelin between pregnant and non-pregnant groups (p > 0.05). However, D3 serum leptin levels 
were significantly lower in pregnant women than non-pregnant women (p < 0.05). 
Conclusions: Lower ghrelin levels in the follicular fluid were associated with higher pregnancy rates. Also, D3 serum leptin 
levels were inversely correlated with clinical pregnancy rates. These findings support the potential role of these molecules 
on IVF outcomes. 
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INTRODUCTION
The regulation of energy intake and energy expenditure 
influences reproduction outcomes via a complex hypothalam-
ic neurocircuitry. Nourishment and low body fat downregulate 
the reproductive axis via circulating factors and hypothalamic 
circuits [1]. Various adipocytokines are involved in the relation-
ship between reproduction and adiposity. Beyond the effect 
on hypothalamo-pituitary axis, these adipocytokines affect 
ovarian intrafollicular interactions at multiple levels, including 
steroidogenesis, metabolic and inflammatory pathways [2]. 
Leptin is an important peripheral signal that indicates 
body fat stores to the hypothalamus and acts within the hy-
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pothalamus to limit food intake. Leptin is a 16 kDa, 146 ami-
no acid protein that is secreted from the adipose tissue. The 
importance of leptin as a signal of fat mass was first demon-
strated in mice in 1994 [3]. Interestedly, leptin-deficient mice 
are infertile and replacement of leptin that exogenously 
restores fertility and prevents obesity [4]. Subsequently, 
its absence and related effects on humans were identified. 
Similar to mice, people treated with exogenous leptin were 
hyperphagic and hyperinsulinemic [5]. Also, excessive leptin 
secretion was related to infertility in obese women [6]. 
In contrast to leptin, ghrelin — a 28 amino acid peptide 
— acts within the hypothalamus to stimulate food inta- 
ke [7]. It is predominantly synthesized in the stomach and 
is an endogenous agonist of the growth hormone secreta-
gogue receptor (GHS-R) [8]. It modulates growth hormone 
secretion suggesting that ghrelin has a separate role in 
antagonizing the actions of leptin to promote food intake 
and weight gain [9]. Ghrelin is effective in GH-deficient rats 
and increases adiposity in chronic exposure in contrast to 
GH [10]. It also stimulates food consumption by increasing 
the respiratory quotient, reducing fatty acid oxidation and 
switching to glycolysis for energy expenditure [11]. Ghrelin 
was also found to suppress the hypothalamic GnRH release 
and GnRH-induced gonadotropin secretion by the hypo-
physis in hypothalamic system in recent reports [12–15]. 
In a recent study, serum and follicular fluid ghrelin levels 
correlated negatively with the cleavage rate and number 
of viable day 3 embryos [15]. 
Although some other studies have investigated the ef-
fect of serum and follicular levels of leptin and ghrelin in 
infertile women undergoing IVF cycles, their results are 
conflicting [15–17]. The exact relationship between clinical 
pregnancy rates and serum/follicular fluid levels of ghrelin 
and leptin remains unclear. Therefore, our goal was to show 
how leptin and ghrelin levels in the serum and follicular fluid 
affect the success of IVF cycles.
MATERIAL AND METHODS
The study population included 44 women who had 
undergone intracytoplasmic sperm injection (ICSI) cycles 
because of unexplained infertility between March 2006 and 
June 2006 at Gülhane Military Medical Academy (Ankara, 
Turkey). The study protocol was approved by the local Ethics 
Committee; informed written consent was obtained from 
all of the participants prior to controlled hyperstimulation.
All of the patients had regular menstrual cycles and nor-
mal ovulatory function as shown by midluteal plasma pro-
gesterone and ultrasonographic scanning. They were of the 
Caucasian race, had normal blood pressure, were non-smok-
ing and not taking any medication, and not involved in 
intensive exercise. Infertility diagnosis included idiopathic 
infertility, patients with a concomitant disease such as uter-
ine anomaly, fibroids, ovarian cyst or pelvic inflammatory 
disease were excluded from the study. The long protocol was 
the method of choice for controlled ovarian hyperstimula-
tion in all cases: 3.75 mg/day of gonadotropin-releasing hor-
mone agonist (Triptorelin)was administrated on day 21 of 
the menstrual cycle preceding oocyte retrieval. After the 
attainment of pituitary desensitization, indicated by serum 
estradiol levels, stimulation was initiated with recombinant 
FSH (Puregon, Organon, The Netherlands). The daily dose 
of gonadotrophins was continued on an individual basis, 
depending upon follicular growth. When the leading follicle 
reached 18 mm in diameter 10.000 IU of hCG was adminis-
tered (Pregnyl, 0rganon, The Netherlands). 34–36 hours after 
the hCG injection, oocytes were recovered by transvaginal 
ultrasound-guided follicle aspiration. After oocyte isolation, 
the follicular fluid was centrifuged at 3000xg for 10 min at 
–4°C to remove debris, blood and granulosa cells, and was 
then frozen at –80°C until evaluation. Follicular fluids that 
were contaminated with significant quantities of blood cells 
were not used for the analysis. Follicle stimulating hormone 
(FSH), luteinizing hormone (LH), and estradiol (E2) serum 
levels at the third day of menstrual cycle and the follicular 
fluid (FF) at the day of oocyte collection were measured. 
Fasting blood samples were obtained on the third day 
of menstruation and on oocyte pick-up (OPU) day. For bio-
chemical examinations, sera were simultaneously separated 
for ghrelin and leptin assays at 4ºC immediately after blood 
sampling. Serum samples were kept frozen at –20oC till bio-
chemical analysis. Leptin concentrations were measured by 
enzyme-linked immunosorbent assay (ELISA) (DRG Diag-
nostic International, Inc., USA), and the samples were read 
with a TRITURUS instrument, (Barcelona, Spain). Within-day 
and between-day assay coefficients of variation of the leptin 
were 4.8% and 8.9%, respectively. The sensitivity of the leptin 
ELISA kit was 0.2 ng/mL. Total serum ghrelin concentrations 
were measured using a commercial radioimmunoassay (RIA) 
that utilizes a 125I-labeled ghrelin as a tracer and a rabbit 
polyclonal antibody raised against full-length octanoylated 
human ghrelin (Phoenix, Europe, Karlsruhe, Germany).(21) 
Samples were read with a LKBWallac, MultiGamma 1261, Turku 
10(Finland). Within-day and between-day assay coefficients of 
variation of the ghrelin were 2.3% and 7.9%, respectively. The 
ghrelin radioimmunoassay (RIA) had a sensitivity of 10 pg/mL. 
Serum and follicular fluid follicle-stimulating hormone (FSH; 
follitropin), luteinizing hormone (LH; lutropin) and estradiol 
levels were measured with a chemiluminescence method and 
an automatic analyzer Immulite® 1000 (Siemens Healthcare 
Diagnostics IL, USA).
Statistical analysis
The SPSS software SPSS 20 (IBM Corp. Released 2011. IBM 
SPSS Statistics for Windows, Version 20.0. Armonk,NY: IBM 
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Corp) was used for the statistical analysis. The continuous 
variables were investigated via the Shapiro-Wilkes test in 
terms of normal distribution. Descriptive statistics were 
expressed as a mean ± standard deviation.The significance 
of the differences between the mean values of the pregnant 
and non-pregnant groups was evaluated by the Student’s 
t-test in parametric conditions, Mann-Whitney U test in 
non-parametric conditions. After single-variable statistical 
analyses, binary logistic regression analysis was performed 
to evaluate the effects of the clinically significant variables 
as well as the variables that affect pregnancy rates. If a sin-
gle variable resulted in a p < 0.25 value, then this variable 
was included in the multiple variable analysis as a possible 
candidate affecting pregnancy rates. The odds ratio and 
95% confidence intervals were evaluated for each variable; 
p < 0.05 was considered to be statistically significant.
RESULTS
19 of the 44 women achieved clinical pregnancy 
(43.18%). There were no statistically significant differences 
between pregnant and non-pregnant women in terms of 
age, BMI, D3 FSH, D3 LH, duration of infertility, the number 
of oocytes, OPU E2, the number of embryos transferred (ET), 
D3 endometrial thickness, OPU day endometrial thickness 
and gonadotropin dosage respectively (Table 1).
There were no statistically significant differences be-
tween pregnant and non-pregnant groups regarding 
D3 serum, OPU serum ghrelin levels as well as FF and OPU 
leptin levels. However, FF ghrelin levels were significantly 
lower in the pregnant group than non-pregnant group 
(79.37 ± 43.12 and 145.65 ± 113.86 ng/mL respectively 
p < 0.05) (Table 2). Also, the mean D3 leptin levels were 
lower in the pregnant group, and the difference was statisti-
cally significant (899.93 ± 61.79 and 937.51 ± 45.18 pg/mL 
respectively, p < 0.05) (Table 2).
To evaluate the relationship between D3 serum, FF lep-
tin, ghrelin values with clinical pregnancies, binary logistic 
regression analysis was performed. As a result of this analy-
sis, D3 serum leptin levels were found to be negative and 
independently correlated with clinical pregnancies relative 
to all other parameters investigated including BMI and age 
(OR: 0.956, p = 0.039) (Table 3).
DISCUSSION
The aim of this prospective cohort study was to evaluate 
the relationship between the outcome of assisted reproduc-
Table 1. Baseline characteristics of pregnant and non-pregnant patients
Variable Pregnant (n: 19) Non-pregnant (n: 25) P value
Age (years) 29.50 ± 4.18 31.22 ± 4.17 0.214
BMI [kg/m2] 24.91 ± 3.68 25.8 ± 3.93 0.510
D3 FSH [mIU/mL] 6.08 ± 3.74 7.21 ± 3.87 0.338
D3 LH [mIU/mL] 7.29 ± 3.66 8.06 ± 3.48 0.455
Duration of infertility (years) 9.38 ± 4.70 9.18 ± 3.25 0.881
Number of oocytes 12.79 ± 5.64 9.8 ± 6.03 0.101
OPU E2 [pg/mL] 3229.25 ± 1490.57 2725.19 ± 2045.27 0.432
Number of ET 2.37 ± 0.6 2.16 ± 0.99 0.421
D3 endometrial thickness [mm] 4.97 ± 0.44 4.88 ± 0.32 0.661
OPU day endometrial thickness [mm] 9.07 ± 1.12 8.69 ± 1.22 0.425
Total dose of gonadotropin [IU] 2178 ± 456.5 2327.5 ± 528.6 0.573
Table 2. Comparison of D3, FF, OPU leptin and ghrelin levels in the two groups
Variable Pregnant (n: 19) Non pregnant (n: 25) P value
FF FSH [mIU/mL] 4.61 ± 2.98 5.75 ± 3.64 0.273
FF LH [mIU/mL] 5.66 ± 2.83 6.65 ± 4.37 0.273
D3 ghrelin [ng/mL] 10.2 ± 5.92 9.15 ± 3.99 0.488
FF ghrelin [ng/mL] 79.37 ± 43.12 145.65 ± 113.86 0.021
OPU ghrelin [ng/mL] 10.42 ± 7.60 9.52 ± 4.33 0.621
FF leptin [pg/mL] 922.89 ± 53.08 885.78 ± 143.54 0.291
OPU leptin [pg/mL] 956.89 ± 50.97 920.47 ± 85.31 0.107
D3 leptin [pg/mL] 899.93 ± 61.79 937.52 ± 45.18 0.025
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tion cycles as a function of leptin and ghrelin levels in FF, 
D3 serum, and OPU serum. The data suggest that of the 
parameters investigated, follicular fluid ghrelin levels and 
D3 serum leptin levels negatively correlated with pregnancy 
rates regardless of the other parameters (especially BMI and 
age) the D3 serum leptin levels were lower in the pregnant 
group, the difference was statistically significant.
Reproduction is a sophisticated function that depends 
on adequate energy and homeostasis [18]. Several stud-
ies have demonstrated the complex relationship between 
adipocytokines and reproduction as well as between fat 
reserves and fertility. Leptin and ghrelin are the two key 
functional antagonists in the control of metabolism and 
energy homeostasis [19]. Thus, we decided to study serum 
and FF levels of these two hormones to understand their 
direct relationship on clinical pregnancy rates. Focusing on 
FF levels would show their effect on the ovarian environ-
ment, but it should be kept in the mind that endometrial 
implantation and embryonic development are also part 
of reproduction. Thus, only FF levels would be insufficient 
to show the reproductive effects of these hormones [20]. 
Several studies have shown the effect of leptin and ghrelin 
on endometrial receptivity. Therefore, clinical pregnancy 
rates would be improved [21–23].
Leptin can act at any level of reproduction from HPG to 
gametogenesis. It seems to be mandatory for normal repro-
ductive function [24]. However, observations of the positive 
effects of leptin on oocytes from several animal studies 
have shown that the definite effect of leptin on reproduc-
tive organs remains unknown [24–26]. Most studies show 
a negative correlation between leptin and IVF outcomes 
like embryo quality, fertilization and pregnancy rates [16, 
17, 27]. Others suggest that there is no correlation [28]. 
More recently, increased leptin levels have indicated better 
IVF outcomes [29]. Thus, the relationship between leptin and 
reproduction remains vague. 
Most studies regarding serum levels of leptin and re-
production assess the increase in leptin levels during ovar-
ian hyperstimulation. Therefore, one might study the effect 
of hyperstimulation on leptin levels rather than the effect 
of leptin on IVF outcomes. Similar to our study, Brannian et 
al., investigated the relationship between reproductive 
outcomes and baseline (D3) serum leptin levels/BMI. They 
found that low levels of leptin/BMI were related to high 
IVF success. They adjusted serum leptin levels, according 
to BMI [30]. In our data analysis, we adjusted serum leptin 
levels, according to all parameters including BMI and age 
similar to Brannian et al. We found a negative correlation 
between D3 serum leptin levels and clinical pregnancies 
— this is absolutely the main parameter showing the success 
of IVF. Our data suggest that D3 serum leptin levels could 
be a simple tool to predict IVF success after adjustment for 
other parameters. 
The effect of ghrelin on the regulation of the reproduc-
tive system has not been equally assessed versus other 
physiological functions of this peptide hormone [31]. Ghre-
lin is a metabolic antagonist of leptin and is an indicator of 
energy insufficiency. It was supposed to have a negative ef-
fect on reproductive biology because of its suppressing role 
in GnRH [12]. Also, it was suggested that Ghrelin might have 
an autocrine-paracrine role in the ovary. Thus it was shown 
that ghrelin exerted an inhibitory effect on granulosa-lutein 
cells steroidogenesis by acting through its functional recep-
tor GHs-R1a [32]. Ghrelin was also shown to inhibit the de-
velopment of mouse preimplantation embryos in vitro [33]. 
Recently Li et al. reported a negative association between 
follicular fluid ghrelin and embryo development, possibly 
through interactions with follicular fluid insulin [15]. Our 
Table 3. Odds ratios of the variables as a result of binary logistic regression analysis
Variable Odds ratio
95% confidence interval
P value
Lower Upper
Age 2.144 0.840 5.477 0.111
BMI 0.677 0.410 1.115 0.126
Day3 FSH 1.606 0.540 4.782 0.395
Day3 LH 0.985 0.530 1.829 0.961
OPU FSH 0.345 0.086 1.384 0.133
OPU E2 1.002 1.000 1.004 0.103
FF ghrelin 0.975 0.946 1.006 0.110
FF leptin 1.016 0.997 1.036 0.098
OPU leptin 1.042 1.002 1.085 0.055
Day3 leptin 0.956 0.915 0.998 0.039
D3 endometrial thickness 1.702 1.433 2.170 0.632
OPU day endometrial thickness 2.644 2.018 3.645 0.298
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data also suggested that there was a negative relationship 
between follicular fluid ghrelin levels and pregnancy rate. 
Thus, the definite effect of ghrelin on reproductive function 
is debated and needs further investigation.
CONCLUSION
In conclusion, although baseline (D3) serum leptin levels 
and follicular fluid ghrelin levels might be prognostic tools 
for IVF outcomes, but our sample size was limited. Thus, we 
believe that further investigations both regarding the effect 
of leptin and ghrelin on IVF success should be carried out 
in the near future on this subject matter.
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